Mechanism terms explain biological plausibility and target language.
Dictionary / Mechanism concept
Receptor binding
Evidence language for interaction with a target, not automatic clinical effect.
Mechanism conceptterm category
0related public pages
editorial navigationdefinition status
draftreview status
9exact evidence rows
5exact source links
0nearby evidence rows
0nearby source links
0do-not-confuse links
0entity links
This page is a dictionary definition and navigation aid. Exact evidence rows below come from approved workbench claims; broader claims and citations live on the related source-backed pages.
Dictionary Reader Map
Use the definition as a doorway, not a conclusion.
Receptor binding explains vocabulary used across the cannabinoid encyclopedia. The definition orients the reader; exact rows and related pages carry the source-backed claims.
5 direct sources linked to approved workbench claims. PubMed 40967679
0 nearby evidence rows and 0 nearby source links.
Aliases help readers find the same concept without changing the evidence standard.
Plain-Language Definition
What it means here
Receptor binding is used in this encyclopedia as a mechanism concept term. Evidence language for interaction with a target, not automatic clinical effect.
Mechanism terms explain biological plausibility. They belong near targets, pathways, models, and assays, but they should not be read as proof that a consumer outcome has been demonstrated.
No common aliases are listed for this term yet.
Evidence Guardrail
How to read it without overreaching
Mechanistic language can explain why researchers care about a compound or target, but it should not silently become a human-health conclusion. Look for related human outcome pages before reading it as clinical evidence.
Evidence Lens
What this term can currently point to
Direct approved claim rows linked to this dictionary term. PubMed 40967679
Distinct source records under those exact rows. PubMed 40967679
Source-backed public pages where this vocabulary is likely useful.
Evidence rows available on those related public pages.
Exact rows are direct evidence links. Use them first, then use related pages to understand the broader research context.
Source Path
How to move from this definition to research
- Read the definition.Use it to understand the vocabulary in plain English.
- Check exact rows.When direct rows exist, open the linked PubMed or DOI record. PubMed 40967679
- Open related pages.Use nearby pages for broader source-backed context.
- Keep the boundary.Mechanism language should not silently become a human-outcome claim.
Exact Evidence Rows
Approved source-backed rows linked to this term
9 exact rows
No matching evidence rows.
Evidence Group
Insufficient
4 exact rows / 2 sources
Evidence row 517 / uses term
CBN modulates receptor, target, metabolic, or pharmacology mechanisms.
insufficient / very_low confidence.
Chemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms. PubMed 40967679
Claim or source metadata contains an explicit term marker.
Evidence row 568 / uses term
CBG modulates receptor, target, metabolic, or pharmacology mechanisms.
insufficient / very_low confidence.
Chemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms. PubMed 40967679
Claim or source metadata contains an explicit term marker.
Evidence row 663 / uses term
CBC modulates receptor, transporter, target, metabolic, or pharmacology mechanisms.
insufficient / very_low confidence.
Chemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms. PubMed 40967679
Claim or source metadata contains an explicit term marker.
Evidence row 670 / uses term
CBC modulates receptor, transporter, target, metabolic, or pharmacology mechanisms.
insufficient / very_low confidence.
Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. PubMed 39769302
Claim or source metadata contains an explicit term marker.
Evidence Group
Mechanistic or Pharmacological
5 exact rows / 4 sources
Evidence row 611 / uses term
CBG studied for Skin and inflammatory dermatology.
mechanistic or pharmacological / very_low confidence.
Anti-Inflammatory Effects of Cannabigerol In Vitro and In Vivo Are Mediated Through the JAK/STAT/NFκB Signaling Pathway. PubMed 39851511
Claim or source metadata contains an explicit term marker.
Evidence row 708 / uses term
CBC studied for Skin and inflammatory dermatology.
mechanistic or pharmacological / very_low confidence.
Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. PubMed 39769302
Claim or source metadata contains an explicit term marker.
Evidence row 727 / uses term
CBC studied for neurobehavioral, mood, neural stem cell, or neurogenesis outcomes.
mechanistic or pharmacological / very_low confidence.
Cannabichromene as a Novel Inhibitor of Th2 Cytokine and JAK/STAT Pathway Activation in Atopic Dermatitis Models. PubMed 39769302
Claim or source metadata contains an explicit term marker.
Evidence row 815 / uses term
Endocannabinoids modulates CB1.
mechanistic or pharmacological / very_low confidence.
Assay of CB1 Receptor Binding. PubMed 27245890
Claim or source metadata contains an explicit term marker.
Evidence row 874 / uses term
THC modulates CB2.
mechanistic or pharmacological / very_low confidence.
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. PubMed 26124120
Claim or source metadata contains an explicit term marker.
Source-Backed Connections
Related pages in the current encyclopedia
No source-backed public page is linked to this term in the current launch set yet. Start with the evidence method, then add sources as the term page matures.
Nearby Terms